MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

HUM · NYSE

Humana Inc.

Health Care · Medical Specialities

Reference price$388.71As of Jul 28, 2026
Market capitalization$46.67B
52-week range$163.11–$428.88
S&P 500 portfolio weight0.07%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$195.00-49.8% vs. reference
Average$363.78-6.4% vs. reference
High$624.00+60.5% vs. reference
7 Buy10 Hold2 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportNot availableJun 2026
Consensus EPS$6.229 estimates
Expected range$1.61–$7.94Low to high EPS
Dec 2026$9.46Street EPS consensus
Dec 2027$15.52Street EPS consensus
Dec 2028$26.36Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+10.1% YoY$130B$118B
Operating income$2.7B$2.56B
Net income$1.19B$1.21B
Operating cash flow$0.92B$2.97B
Capital expenditures($0.55B)($0.58B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

Gear Up for Humana (HUM) Q2 Earnings: Wall Street Estimates for Key Metrics

Zacks

The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals

Zacks

4 Medical Stocks With the Right Setup for Q2 Earnings Beats

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.